Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Status:
Completed
Trial end date:
2016-07-16
Target enrollment:
Participant gender:
Summary
This phase II trial studies the effectiveness of paclitaxel in treating patients who have
ovarian stromal cancer. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.